Horizon Therapeutics fields buyout interest from Amgen, J&J and Sanofi

Horizon Therapeutics Plc said on Tuesday its board was engaged in highly preliminary discussions with Amgen Inc, Sanofi and Johnson & Johnson unit Janssen Global Services for potential takeover offers.

The biotech company, which has a market capitalization of $17.7 billion, added there can be no certainty that any offer will be made. Horizon Therapeutics makes drugs for rare, autoimmune and severe inflammatory diseases.